B C Turner
Overview
Explore the profile of B C Turner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
742
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Castillo R, John R, Turner B, Zimmerman E, Schwartz D
J Acquir Immune Defic Syndr
. 2000 Sep;
24(3):197-202.
PMID: 10969342
We have described a peripheral blood mononuclear cell (PBMC) culture system in which control of endogenous virus and resistance to exogenous HIV-1 correlates with low viremia among HIV-1-positive people. Nineteen...
12.
Turner B, Gumbs A, Carter D, Glazer P, Haffty B
Int J Radiat Oncol Biol Phys
. 2000 Jul;
47(5):1169-76.
PMID: 10889369
Purpose: The purpose of this study was to determine the prognostic significance of cyclin D1 (cycD1) levels in ipsilateral breast tumor recurrence (IBTR) following lumpectomy and radiation therapy. Methods And...
13.
Krajewski S, Krajewska M, Turner B, Pratt C, Howard B, Zapata J, et al.
Endocr Relat Cancer
. 2000 Mar;
6(1):29-40.
PMID: 10732784
Dysregulation of normal programmed cell death mechanisms plays an important role in the pathogenesis and progression of breast cancer, as well as in responses of tumors to therapeutic intervention. Overexpression...
14.
Yoo S, Carter D, Turner B, Sasaki C, Son Y, Wilson L, et al.
Int J Cancer
. 2000 Mar;
90(1):22-8.
PMID: 10725854
Recent laboratory experiments have demonstrated that cyclin D1 levels (cycD1) can influence radiosensitivity. The purpose of the current study is to evaluate the prognostic significance of cycD1 for local recurrence...
15.
Lehman T, Haffty B, Carbone C, Bishop L, Gumbs A, Krishnan S, et al.
Cancer Res
. 2000 Mar;
60(4):1062-9.
PMID: 10706125
Previous studies have determined that the frequency of germ-line p53 mutations in familial breast cancer patients is 1% or less, but these reports have not investigated the importance of polymorphic...
16.
Turner B, Gumbs A, Carbone C, Carter D, Glazer P, Haffty B
Cancer
. 2000 Mar;
88(5):1091-8.
PMID: 10699900
Background: The p53 tumor suppressor gene encodes a nuclear phosphoprotein that is thought to be important to cell cycle regulation and DNA repair and that also may regulate induction of...
17.
Turner B, Glazer P, Haffty B
J Clin Oncol
. 1999 Nov;
17(11):3689.
PMID: 10550169
No abstract available.
18.
Turner B, Harrold E, Matloff E, Smith T, Gumbs A, Beinfield M, et al.
J Clin Oncol
. 1999 Oct;
17(10):3017-24.
PMID: 10506595
Purpose: Breast cancer patients treated conservatively with lumpectomy and radiation therapy (LRT) have an estimated lifetime risk of local relapse (ipsilateral breast tumor recurrence [IBTR]) of 10% to 15%. For...
19.
Turner B, Zhang J, Gumbs A, Maher M, Kaplan L, Carter D, et al.
Cancer Res
. 1998 Dec;
58(23):5466-72.
PMID: 9850080
The AP-2 transcription factors are required for normal growth and morphogenesis during mammalian development. Previous in vitro studies have also indicated that the AP-2 family of proteins may be involved...
20.
Harrold E, Turner B, Matloff E, Pathare P, Beinfield M, MCKHANN C, et al.
Cancer J Sci Am
. 1998 Nov;
4(5):302-7.
PMID: 9815294
Background: The purpose of this study was to evaluate the relationships among young age at diagnosis, family history status, and local recurrence in breast cancer patients treated with lumpectomy and...